Masimo Corp (MASI)
172.96
+3.84
(+2.27%)
USD |
NASDAQ |
Nov 22, 16:00
173.07
+0.11
(+0.06%)
Pre-Market: 20:00
Masimo Free Cash Flow: 149.60M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 149.60M |
| June 30, 2024 | 111.10M |
| March 31, 2024 | 51.20M |
| December 31, 2023 | 6.40M |
| September 30, 2023 | -58.40M |
| June 30, 2023 | -28.30M |
| March 31, 2023 | -44.90M |
| December 31, 2022 | -26.90M |
| September 30, 2022 | 77.60M |
| June 30, 2022 | 146.80M |
| March 31, 2022 | 181.12M |
| December 31, 2021 | 229.70M |
| September 30, 2021 | 188.64M |
| June 30, 2021 | 148.72M |
| March 31, 2021 | 175.77M |
| December 31, 2020 | 131.20M |
| September 30, 2020 | 137.53M |
| June 30, 2020 | 148.19M |
| March 31, 2020 | 118.90M |
| December 31, 2019 | 149.15M |
| September 30, 2019 | 149.94M |
| June 30, 2019 | 153.46M |
| March 31, 2019 | 186.68M |
| December 31, 2018 | 216.84M |
| September 30, 2018 | 201.26M |
| Date | Value |
|---|---|
| June 30, 2018 | 149.47M |
| March 31, 2018 | 65.25M |
| December 31, 2017 | 9.299M |
| September 30, 2017 | 291.74M |
| June 30, 2017 | 324.82M |
| March 31, 2017 | 390.74M |
| December 31, 2016 | 394.77M |
| September 30, 2016 | 121.25M |
| June 30, 2016 | 105.86M |
| March 31, 2016 | 74.15M |
| December 31, 2015 | 62.61M |
| September 30, 2015 | 31.18M |
| June 30, 2015 | 43.18M |
| March 31, 2015 | -2.475M |
| December 31, 2014 | 16.65M |
| September 30, 2014 | 0.184M |
| June 30, 2014 | -10.18M |
| March 31, 2014 | 39.44M |
| December 31, 2013 | 41.30M |
| September 30, 2013 | 53.01M |
| June 30, 2013 | 62.15M |
| March 31, 2013 | 62.29M |
| December 31, 2012 | 60.94M |
| September 30, 2012 | 68.85M |
| June 30, 2012 | 64.74M |
Free Cash Flow Range, Past 5 Years
-58.40M
Minimum
Sep 2023
229.70M
Maximum
Dec 2021
99.66M
Average
134.37M
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| Baxter International Inc | 391.00M |
| Intuitive Surgical Inc | 586.00M |
| Tandem Diabetes Care Inc | -37.35M |
| Glaukos Corp | -81.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 25.60M |
| Cash from Investing (Quarterly) | -13.50M |
| Cash from Financing (Quarterly) | -1.60M |
| Free Cash Flow Per Share (Quarterly) | 0.1731 |
| Free Cash Flow to Equity (Quarterly) | 18.40M |
| Free Cash Flow to Firm (Quarterly) | 17.17M |
| Free Cash Flow Yield | 1.59% |